Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060760

EVP & Chief Commercial Officer sold 303 shares at $81.14 ($24,585)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-14 Sale : show line 1 in the form −303 $81.14 $24,585 25,030 D
Open-market sales · 303 sh · avg $81.14 · $24,585
Loading xslF345X03/doc4.xml…